Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Health Care

Health Care

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Biotech
  • Earnings
  • FDA
  • General
  • Health Care
  • Movers
  • News
  • Small Cap

Why Is Gene Therapy Player PTC Therapeutics Stock Plunging Today?

By Vandana Singh
October 27, 1:00 PM
In its Q3 earnings release, PTC Therapeutics Inc (NASDAQ: PTCT) reported a 

BMRN

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • News

Questions Surround Vertex/CRISPR’s Sickle Cell Gene Therapy As FDA AdComm Meeting Approaches

By Vandana Singh
October 27, 12:57 PM
The FDA's Cellular, Tissue, and Gene Therapies Advisory Committee will meet next 

CRSP

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • News

FDA Gives Nod To Eli Lilly’s First Treatment For Type Of Inflammatory Bowel Disease, To Compete With JNJ, Pfizer, AbbVie

By Vandana Singh
October 27, 10:28 AM
The FDA approved Eli Lilly And Co's 

ABBV

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News

Why Is Clinical Diagnostic-Focused Bio-Rad Stock Trading Lower Today?

By Vandana Singh
October 27, 10:21 AM
Bio-Rad Laboratories Inc (NYSE: BIO) shares are trading lower after the company lowered its annual revenue growth forecast, citing the uncertain pace of the biopharma sector's recovery and the 

BIO

Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

AbbVie Raises Annual Profit Outlook As Newer Immunology Drugs Help Cushion Struggling Humira Sales

By Vandana Singh
October 27, 9:56 AM
AbbVie Inc (NYSE: ABBV) has reported Q3 adjusted EPS of $2.95, down 19.4% Y/Y, beating the consensus of $2.88.

ABBV

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Weight Loss Drugs Like Wegovy Would Not Impact Business – Healthcare Companies Tell Investors

By Vandana Singh
October 27, 7:51 AM
Novo Nordisk A/S (NYSE: NVO) investors and analysts eagerly await the company's third-quarter results, hoping for clarity on when supply limitations for its weight-loss drug, Wegovy, in the U.S. 

LLY

Read More
2 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Sanofi Goes The Rival Way: Plans Separation Of Consumer Healthcare Unit

By Vandana Singh
October 27, 7:44 AM
Sanofi SA (NASDAQ: SNY) plans to spin off its consumer healthcare business as the French pharmaceutical company outlined its strategic update to increase investment in its drug-development pipeline and cut costs.

SNY

Read More
2 minute read
  • Equities
  • General
  • Health Care
  • Markets
  • News

Biogen Says New Data Shows Promise For Potential New Generation Of Treatments In Early Alzheimer’s Disease

By Nabaparna Bhattacharya
October 25, 12:20 PM
Biogen Inc. (NASDAQ: BIIB) reported new Phase 1b clinical data from the study of BIIB080, an investigational antisense oligonucleotide (ASO) therapy targeting tau,

BIIB

Read More
1 minute read
  • After-Hours Center
  • General
  • Health Care
  • News

Why Medpace Holdings Stock Is Rising After-Hours

By Ryan Gustafson
October 23, 5:15 PM
Medpace Holdings Inc  (NASDAQ: MEDP) shares are trading higher in Monday's after-hours session after the company released its third-quarter results.

MEDP

Read More
1 minute read
  • Asset Sales
  • Equities
  • General
  • Health Care
  • Large Cap
  • M&A
  • Markets
  • News

Roche Buys Pfizer & Roivant Sciences’ Televant In ~$7.1B Deal

By Lekha Gupta
October 23, 8:55 AM
Roche Holding AG (OTC: RHHBY) inked a deal to acquire 

PFE

Posts pagination

Previous 1 … 133 134 135 … 478 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service